file:: [0-_Guidelines_for_TIVA_1708011925990_0.pdf](../assets/0-_Guidelines_for_TIVA_1708011925990_0.pdf)
file-path:: ../assets/0-_Guidelines_for_TIVA_1708011925990_0.pdf

- Achieving a stable plasma concentration of a drug requires varying drug infusion rates.
  ls-type:: annotation
  hl-page:: 4
  hl-color:: yellow
  id:: 65ce3200-8dde-4d46-b449-dd5f3ca19ef7
- The drug concentration achieved in the plasma and brain can be predicted from pharmacokinetic models
  ls-type:: annotation
  hl-page:: 4
  hl-color:: yellow
  id:: 65ce3217-f49b-4a9d-87b3-7d5cfd254cf9
- A pharmacokinetic model is a mathematical description of the distribution, metabolism and elimination of a drug in the body.
  ls-type:: annotation
  hl-page:: 13
  hl-color:: yellow
  id:: 65ce3272-8088-4447-ae95-ce2df779e814
- The pharmacokinetic behaviour of most anaesthetic drugs used for TIVA can be predicted with a three-compartment model
  ls-type:: annotation
  hl-page:: 13
  hl-color:: yellow
  id:: 65ce32b7-4f5f-43ce-b7ed-7c3f005e5bca
- These volumes and rate constants are determined from studies in which the drug is administered to volunteers or patients by bolus, infusion or both, following which timed blood samples are taken to assay drug concentrations
  ls-type:: annotation
  hl-page:: 13
  hl-color:: green
  id:: 65ce3524-7367-406a-a101-8765161a5ca4
- Mathematical modelling software is used to estimate these pharmacokinetic variables in individual subjects, and then to estimate the inﬂuence of potential covariates such as body weight and age on these variables.
  ls-type:: annotation
  hl-page:: 13
  hl-color:: green
  id:: 65ce353a-76d6-4a57-85c6-c9c299d71e38
- A TCI pump contains a microprocessor programmed with pharmacokinetic models for relevant drugs
  ls-type:: annotation
  hl-page:: 13
  hl-color:: yellow
  id:: 65ce3561-a96c-41a9-9325-f4f99af93617
- The user selects the drug and pharmacokinetic model to be used by that TCI pump, and inputs the patient characteristics(covariates) and the desired (‘target’) initial blood concentration. 
  ls-type:: annotation
  hl-page:: 13
  hl-color:: yellow
  id:: 65ce356e-e1bd-4891-82b6-2a4c77557596
- Once started, the system delivers a bolus as a fast infusion (600–1200 ml.h1) to achieve the target concentration in V1 
  ls-type:: annotation
  hl-page:: 13
  hl-color:: yellow
  id:: 65ce357a-2370-4255-961c-653a90107c40
- For a stable plasma concentration, the amount of drug metabolised per minute is constant, while the net movement of drug between compartments gradually decreases as gradients equalise.
  ls-type:: annotation
  hl-page:: 13
  hl-color:: yellow
  id:: 65ce3592-fa50-48ab-801f-5b07f92169d3
- Effect-site targeting is a TCI mode in which the user inputs a target effect-site (brain) concentration 
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce37fc-f596-408f-9c96-9b30f53423b8
- Marsh
  ls-type:: annotation
  hl-page:: 14
  hl-color:: red
  id:: 65ce3920-9370-48f2-945f-3c80b7933783
- Schnider
  ls-type:: annotation
  hl-page:: 14
  hl-color:: red
  id:: 65ce3922-d860-4d3d-8225-94c3815d3c60
- Both were derived from studies involving healthy adults and did not include obese or older patients 
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce3929-dde0-4875-8d9e-562625d2c779
- The Marsh model i
  ls-type:: annotation
  hl-page:: 14
  hl-color:: red
  id:: 65ce398c-7bc1-4540-a6ce-2c089bbf1f74
- Diprifusor
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce3991-ad1f-49c5-bcff-b31ce7fb10a1
- only offer plasma targeting
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce3998-1ad1-4f9a-9ec4-cd7bae309036
- The original model had no ke0
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce39a7-bbc2-4284-a532-9ace8de95c5f
- ater versions of the Diprifusor used the Marsh model together with a ke0 of 0.26 min1 to calculate and display an estimated effect-site concentration for information purposes. 
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce39b3-63a3-4b41-87c0-2b742aaa0cd9
- Most newer ‘open TCI’ pumps that offer effect-site targeting with the Marsh model use a more rapid ke0 (e.g.1.2 min1) to avoid excessively large loading doses.
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce39c1-2962-441c-9751-1afe6970626d
- The Schnider model
  ls-type:: annotation
  hl-page:: 14
  hl-color:: red
  id:: 65ce3a96-7863-4d8d-af3e-fd6fce67288f
- The Schnider model should routinely be used in effect-site targeting mode. 
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce3b1d-e523-48ea-8732-c944461374c0
- n most patients, induction doses are similar to those provided by the Marsh model in plasma targeting mode because a smaller V1 is used in the Schnider model.
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce3b30-5bfe-4bb0-a8eb-d63d1e550398
- Thereafter, for the same target concentration, in most patients infusion rates will be somewhat higher with the Marsh model than when the Schnider model is used.
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce3b42-2457-4584-a781-6a167a968f5f
- For an average healthy young adult of normal proportions, this scheme will achieve a plasma concentration of approximately 3 lg.ml1 .
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce400b-c92f-44bf-95f7-b1c9daf1425c
- in the study by Roberts et al., temazepam premedication, intravenous fentanyl and inhaled nitrous oxide were all given in addition to propofol
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce402a-79fd-42cf-999a-344c5e86e44b
- The Minto model 
  ls-type:: annotation
  hl-page:: 14
  hl-color:: red
  id:: 65ce406e-0139-49c9-a6e2-6786928cbff5
- the calculation is only valid in patients who have a BMI < 35 kg.m2 in females and < 42 kg.m2 in males.
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce40d3-769c-4bf1-bd22-260122050661
- Typical maintenance doses of remifentanil are in the order of 0.08–0.25 lg.kg1.min1 which are equivalent to plasma concentrations of approx. 2–6 ng.ml1
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce40e6-2132-4dcb-b077-92bb0f788bce
- In young or middle-aged healthy adults of normal proportions, a plasma concentration appropriate for tracheal intubation (approximately 6 ng.ml1) can be achieved reasonably quickly by giving a loading dose in the form of an initial rapid infusion of 0.5 lg.kg1.min1 with a step down to 0.25 lg.kg1.min1 after 3 min. 
  ls-type:: annotation
  hl-page:: 14
  hl-color:: yellow
  id:: 65ce4106-52e5-48f7-9aa6-fd49696681ec